Currently, there are 110.44M common shares owned by the public and among those 104.75M shares have been available to trade.
The company’s stock has a 5-day price change of -8.54% and -16.91% over the past three months. WAL shares are trading -14.46% year to date (YTD), with the 12-month market performance up to 10.47% higher. It has a 12-month low price of $56.70 and touched a high of $98.10 over the same period. WAL has an average intraday trading volume of 1.24 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -3.60%, -1.15%, and -12.90% respectively.
Institutional ownership of Western Alliance Bancorp (NYSE: WAL) shares accounts for 88.56% of the company’s 110.44M shares outstanding.
It has a market capitalization of $7.89B and a beta (3y monthly) value of 1.29. The stock’s trailing 12-month PE ratio is 9.82, while the earnings-per-share (ttm) stands at $7.28. The company has a PEG of 0.54 and the debt-to-equity ratio at 0.75. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.37% over the week and 2.48% over the month.
Analysts forecast that Western Alliance Bancorp (WAL) will achieve an EPS of 2.02 for the current quarter, 2.31 for the next quarter and 10.48 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 1.89 while analysts give the company a high EPS estimate of 1.89. Comparatively, EPS for the current quarter was 1.7 a year ago. Earnings per share for the fiscal year are expected to increase by 21.98%, and 21.83% over the next financial year. EPS should grow at an annualized rate of 18.12% over the next five years, compared to 7.93% over the past 5-year period.
Looking at the support for the WAL, a number of firms have released research notes about the stock. Jefferies stated their Buy rating for the stock in a research note on May 21, 2025, with the firm’s price target at $95. Truist coverage for the Western Alliance Bancorp (WAL) stock in a research note released on May 13, 2025 offered a Buy rating with a price target of $92. UBS was of a view on December 17, 2024 that the stock is Buy, while Deutsche Bank gave the stock Buy rating on October 07, 2024, issuing a price target of $83- $101. Hovde Group on their part issued Outperform rating on April 22, 2024.
